BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32920953)

  • 1. Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines.
    McKelvey BA; Zeiger MA; Umbricht CB
    Mol Oncol; 2020 Oct; 14(10):2355-2357. PubMed ID: 32920953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers.
    Rowland TJ; Bonham AJ; Cech TR
    Mol Oncol; 2020 Oct; 14(10):2358-2374. PubMed ID: 33245585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pervasive promoter hypermethylation of silenced TERT alleles in human cancers.
    Esopi D; Graham MK; Brosnan-Cashman JA; Meyers J; Vaghasia A; Gupta A; Kumar B; Haffner MC; Heaphy CM; De Marzo AM; Meeker AK; Nelson WG; Wheelan SJ; Yegnasubramanian S
    Cell Oncol (Dordr); 2020 Oct; 43(5):847-861. PubMed ID: 32468444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
    Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
    Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
    McKelvey BA; Gilpatrick T; Wang Y; Timp W; Umbricht CB; Zeiger MA
    Thyroid; 2020 Oct; 30(10):1470-1481. PubMed ID: 32228178
    [No Abstract]   [Full Text] [Related]  

  • 6. Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.
    Stern JL; Paucek RD; Huang FW; Ghandi M; Nwumeh R; Costello JC; Cech TR
    Cell Rep; 2017 Dec; 21(13):3700-3707. PubMed ID: 29281820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation of the TERT promoter and its impact on human cancer.
    Lee DD; Komosa M; Nunes NM; Tabori U
    Curr Opin Genet Dev; 2020 Feb; 60():17-24. PubMed ID: 32114294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TERT Promoter Methylation Is Oxygen-Sensitive and Regulates Telomerase Activity.
    Dogan F; Forsyth NR
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38275760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
    Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
    Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.
    Salgado C; Roelse C; Nell R; Gruis N; van Doorn R; van der Velden P
    PLoS One; 2020; 15(4):e0231418. PubMed ID: 32267900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
    Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
    J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of telomerase in cancer.
    Akincilar SC; Unal B; Tergaonkar V
    Cell Mol Life Sci; 2016 Apr; 73(8):1659-70. PubMed ID: 26846696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
    McKelvey BA; Umbricht CB; Zeiger MA
    Front Endocrinol (Lausanne); 2020; 11():485. PubMed ID: 32849278
    [No Abstract]   [Full Text] [Related]  

  • 14. Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines.
    Losi L; Lauriola A; Tazzioli E; Gozzi G; Scurani L; D'Arca D; Benhattar J
    J Ovarian Res; 2019 Jul; 12(1):62. PubMed ID: 31291979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
    Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
    Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant
    Fotouhi O; Ghaderi M; Wang N; Zedenius J; Kjellman M; Xu D; Juhlin CC; Larsson C
    Epigenetics; 2019 Dec; 14(12):1224-1233. PubMed ID: 31322481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALV Integration-Associated Hypomethylation at the TERT Promoter Locus.
    Lam G; Beemon K
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29439385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.
    Zhang H; Weng X; Ye J; He L; Zhou D; Liu Y
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):600-9. PubMed ID: 25683523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines.
    Hirata M; Fujita K; Fujihara S; Mizuo T; Nakabayashi R; Kono T; Namima D; Fujita N; Yamana H; Kamada H; Tani J; Kobara H; Tsutsui K; Matsuda Y; Ono M; Masaki T
    In Vivo; 2022; 36(1):94-102. PubMed ID: 34972704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA hypermethylation enhanced telomerase reverse transcriptase expression in human-induced pluripotent stem cells.
    Takasawa K; Arai Y; Yamazaki-Inoue M; Toyoda M; Akutsu H; Umezawa A; Nishino K
    Hum Cell; 2018 Jan; 31(1):78-86. PubMed ID: 29103143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.